CVR Medical (OTCMKTS:CRRVF) versus Valion Bio, Inc. Common Stock (NASDAQ:VBIO) Financial Contrast

CVR Medical (OTCMKTS:CRRVF) and Valion Bio, Inc. Common Stock (NASDAQ:VBIO) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership.

Institutional and Insider Ownership

4.3% of Valion Bio, Inc. Common Stock shares are owned by institutional investors. 2.4% of Valion Bio, Inc. Common Stock shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares CVR Medical and Valion Bio, Inc. Common Stock’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CVR Medical	N/A	N/A	N/A
Valion Bio, Inc. Common Stock	N/A	-138.10%	-63.67%

Risk and Volatility

CVR Medical has a beta of 31.85, suggesting that its stock price is 3,085% more volatile than the S&P 500. Comparatively, Valion Bio, Inc. Common Stock has a beta of 1.79, suggesting that its stock price is 79% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and price targets for CVR Medical and Valion Bio, Inc. Common Stock, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVR Medical	0	0	0	0	0.00
Valion Bio, Inc. Common Stock	1	0	0	0	1.00

Given CVR Medical’s higher possible upside, analysts plainly believe CVR Medical is more favorable than Valion Bio, Inc. Common Stock.

Earnings & Valuation

This table compares CVR Medical and Valion Bio, Inc. Common Stock”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVR Medical	N/A	N/A	N/A	($0.02)	N/A
Valion Bio, Inc. Common Stock	$780,000.00	2.85	-$8.88 million	($6.68)	-0.10

CVR Medical has higher earnings, but lower revenue than Valion Bio, Inc. Common Stock. Valion Bio, Inc. Common Stock is trading at a lower price-to-earnings ratio than CVR Medical, indicating that it is currently the more affordable of the two stocks.

Summary

CVR Medical beats Valion Bio, Inc. Common Stock on 5 of the 9 factors compared between the two stocks.

About CVR Medical

CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.

About Valion Bio, Inc. Common Stock

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.